Mechanism of inactivation of human leukocyte elastase by a chloromethyl ketone: kinetic and solvent isotope effect studies
- 23 September 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 25 (19) , 5414-5419
- https://doi.org/10.1021/bi00367a011
Abstract
The mechanism of inactivation of human leukocyte elastase (HLE) by the chloromethyl ketone MeOSuc-Ala-Ala-Pro-Val-CH2Cl was investigated. The dependence of the first-order rate constant for inactivation on concentration of chloromethyl ketone is hyperbolic and suggests formation of a reversible "Michaelis complex" prior to covalent interaction between the enzyme and inhibitor. However, the observed Ki value is 10 .mu.M, at least 10-fold lower than dissociation constants for complexes formed from interaction of HLE with structurally related substrates or reversible inhibitors, and suggests that Ki is a complex kinetic constant, reflecting the formation and accumulation of both the Michaelis complex and a second complex. It is proposed that this second complex is a hemiketal formed from attack of the active site serine on the carbonyl carbon of the inhibitor. The accumulation of this intermediate may be a general feature of reactions of serine proteases and chlromethyl ketones derived from specific peptides and acounts for the very low Ki values observed for these reactions. The solvent deuterium isotope effect (SIE) on the inactivation step (ki) is 1.58 .+-. 0.07 and is consistent with rate-limiting, general-catalyzed attack of the-active site His on the methylene carbon of the inhibitor with displacement of chloride anion. The general catalyst is thought to be the active site Asp. In contrast, the SIE on the second-order rate constant for HLE inactivation, ki/Ki, is inverse and equals 0.64 .+-. 0.05. The proton inventory (rate measurements in mixtures of H2O and D2O) for this reaction is "bowed down" from a straight line connecting the points in pure H2O and D2O and indicates multi-proton reorganization. These results are consistent with a mechanism for ki/Ki in which (i) initial formation of the Michaelis complex is accompanied by solvent reorganization and (ii) the ketone moiety of the inhbitor exists as a fully formed hemiketal in the rate-limiting transition state.This publication has 15 references indexed in Scilit:
- Catalysis by human leukocyte elastase: substrate structural dependence of rate-limiting protolytic catalysis and operation of the charge relay systemJournal of the American Chemical Society, 1983
- Purification of Human Leukocyte Elastase and Cathepsin G by Chromatography on Immobilized ElastinPreparative Biochemistry, 1983
- Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifierBiochemistry, 1982
- The inhibition of crotalase, a thrombin-like snake venom enzyme, by several peptide chloromethyl ketone derivativesBiochemical and Biophysical Research Communications, 1981
- Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinasesBiochimica et Biophysica Acta (BBA) - Enzymology, 1980
- Crystal structure studies and inhibition kinetics of tripeptide chloromethyl ketone inhibitors with Streptomyces griseus protease BJournal of Molecular Biology, 1980
- Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.Journal of Biological Chemistry, 1979
- Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G Inhibition with peptide chloromethyl ketonesBiochimica et Biophysica Acta (BBA) - Enzymology, 1977
- Polypeptide halomethyl ketones bind to serine proteases as analogs of the tetrahedral intermediate. X-ray crystallographic comparison of lysine- and phenylalanine-polypeptide chloromethyl ketone-inhibited subtilisin.Journal of Biological Chemistry, 1976
- Direct Evidence for the Presence of Histidine in the Active Center of Chymotrypsin*Biochemistry, 1963